Document:

ex10five.htm

 

 

 

 

 

WAIVER OF TRIGGER EVENT 

 

This Waiver of Trigger Event (this “Waiver”) is entered into as of October 23, 2009, by and between St. George Investments, LLC, an Illinois limited liability company (“Lender”),
and Radiant Pharmaceuticals, Inc., a Delaware corporation (formerly AMDL, Inc.) (“Borrower”). 

 

A. Borrower previously issued to Lender a certain Convertible Promissory Note dated September 15, 2009 (the “Note”). 

 

B. Pursuant to Section 8(b) of the Note, a decrease below Fifty Thousand Dollars ($50,000.00) in ten-day average daily trading volume of Borrower’s stock results in the occurrence of a Trigger Event (as defined in the Note) under the Note (the “Section
8(b) Trigger Event”). 

 

C. On each of October 20, 2009 and October 21, 2009, the Section 8(b) Trigger Event occurred and Lender notified Borrower of such occurrence pursuant to a certain notice from Lender to Borrower dated October 22, 2009. 

 

D. The occurrence of the Section 8(b) Trigger Event triggered certain provisions under the Note, including the increase of the principal balance of the Note by 125%, the acceleration of all amounts due under the Note, and an increase in the interest rate of the Note to 18%. 

 

E. Borrower desires that Lender waive the Section 8(b) Trigger Event and Lender has agreed to do so subject to the terms and conditions of this Waiver. 

 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 

1. Waiver. Subject to Borrower’s compliance with the terms and conditions of this Waiver, Lender hereby waives the occurrence of the Section 8(b) Trigger Event, effective as of the date the Section 8(b) Trigger Event first occurred, and continuing through December 31,
2009. This Waiver shall not apply to any Trigger Event (including, without limitation, any Section 8(b) Trigger Event) on or after January 1, 2010. On and after January 1, 2010, the existence of any Trigger Event will be determined in all respects as set forth in the Note. 

 

2. Stock Issuance. In consideration of Lender’s waiver set forth in Section 1 above, Borrower shall issue to Lender 250,000 shares of its common stock, $0.001 par value per share (the “Common
Shares”). The Common Shares shall be evidenced by stock certificates issued in Lender’s name and delivered to Lender on or before October 30, 2009. Borrower further agrees to register the Common Shares under the Securities Act of 1933, as amended, on or before December 4, 2009. 

 

3. Failure to Comply. Should Borrower fail to comply with either of the conditions set forth in Section 2 hereof, Lender’s waiver given herein shall immediately be deemed withdrawn and the occurrence of the Trigger Event shall again be effective as of the first date
the Trigger Event occurred. In addition, Lender shall remain entitled to the Common Shares as compensatory damages for Borrower’s breach of its obligations under the terms of this Waiver. 

 

  

  

  

4. Ratification of Note. The Note shall be and remain in full force and effect in accordance with its terms and hereby is ratified and confirmed in all respects. No waiver other than the Section 8(b) Trigger Event may be implied by this Waiver and Lender reserves its rights
with respect to the occurrence of any other Trigger Event at any time. Except as expressly set forth herein, the execution, delivery, and performance of this Waiver shall not operate as a wavier of, or as an amendment of, any right, power, or remedy of Lender under the Note, as in effect prior to the date hereof. 

 

5. Counterparts. This Waiver may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument. 

 

[Remainder of page intentionally left blank] 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

2

  

IN WITNESS WHEREOF, the undersigned have executed this Waiver as of the first date above written. 

 

 

 

	 	
BORROWER: 
	 
	 	 	 
	 	
RADIANT PHARMACEUTICALS, INC. 
	 
	 	 	 
	 	By: _____________________________________________ 	 
	 	Name: Douglas C. MacLellan___________ Title:  	 
	 	Chairman &  CEO______________  	 
	 	 	 
	 	 	 
	 	
LENDER: 

	 
	 	 	 
	 	
ST. GEORGE INVESTMENTS, LLC 
	 
	 	 	 
	 	By: _____________________________________________ 	 
	 	John M. Fife, Manager  	 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Signature page to Waiver of Trigger Event] 

  

3ex10_2.htm

    

      
        

      

    

    
      EXHIBIT
10.2

      

      Supplemental
Note Purchase Agreement

      

      CH
Energy Group, Inc.

      284 South
Avenue

      Poughkeepsie,
New York 12601-4879

      

      As of
December 15, 2009

      

      To Each
of the Purchasers

      Named in
the Supplemental

      Purchaser
Schedule Attached Hereto (each a “Series B
Purchaser")

      

      Ladies
and Gentlemen:

      

      Reference
is made to that certain Note Purchase Agreement, dated as of April 17, 2009
among the Company and each of the Initial Purchasers named in the Initial
Purchaser Schedule attached thereto (the “Agreement”).  Terms
used but not defined herein shall have the respective meanings set forth in the
Agreement.

      

      As
contemplated in Section
2.2 of the Agreement, the Company agrees with you as
follows:

      

      A.Subsequent Series of
Notes.  The Company has authorized and will create a Subsequent
Series of Notes to be called the “Series B
Notes.”  Said Series B Notes will be dated the date of issue;
will bear interest (computed on the basis of a 360-day year of twelve 30-day
months) from such date at the rate of 6.80% per annum, payable semiannually in
arrears on the dates set forth on the Schedule attached thereto as Annex I until the
principal hereof shall have come due and payable and shall bear interest on
overdue principal (including any overdue optional prepayment of principal) and
premium, if any, and, to the extent permitted by law, on any overdue installment
of interest at the rate specified therein after the date due for payment,
whether by acceleration or otherwise, until paid; will be expressed to mature on
December 15, 2025; and will be substantially in the form attached to the
Agreement as Exhibit 1.2 with the
appropriate insertions to reflect the terms and provisions set forth
above.

      

      C.Conditions of Series B
Closing.  The obligation of each Series B Purchaser to purchase
and pay for the Series B Notes to be purchased by such purchaser hereunder on
the Series B Closing Date is subject to the satisfaction, on or before such
Series B Closing Date, of the conditions set forth in Section 4 of the
Agreement, and to the following additional conditions:

      

      (a)Except as supplemented, amended or
superceded by the representations and warranties set forth in Exhibit A hereto, each of the
representations and warranties of the Company set forth in Section 5 of the Agreement
shall be correct as of the Series B Closing Date and the Company shall have
delivered to each Series B Purchaser an Officer’s Certificate, dated the Series
B Closing Date certifying that such condition has been
fulfilled.

      
        
           

        

        
          1

          
            

          

        

        
           

        

      

      (b)Contemporaneously with the Series B
Closing, the Company shall sell to each Series B Purchaser, and each Series B
Purchaser shall purchase, the Series B Notes to be purchased by such Series B
Purchaser at the Series B Closing as specified in the Supplemental Purchaser
Schedule.

      

      D.Prepayments.  The
Series B Notes shall be subject to prepayment only (a) pursuant to the
required prepayments specified in clause (x) below; and (b) pursuant
to the optional prepayments specified in clause (y) below. 

      

      (x) Required Prepayments;
Maturity.  In addition to
paying the remaining outstanding principal amount and the interest due on the
Notes on the maturity date thereof, on the dates set forth on the Schedule
attached hereto as Annex I
until the principal hereof shall have come due and payable the Company
will prepay principal amount (or such lesser principal amount as shall then be
outstanding) of the Notes set forth on the Schedule attached hereto as Annex I at par and
without payment of the Make-Whole Amount or any premium; provided that upon any
partial prepayment of the Notes pursuant to clause (y) below, the principal
amount of each required prepayment of the Notes becoming due under this
clause (x) on and after the date of such prepayment shall be reduced in the
same proportion as the aggregate unpaid principal amount of the Notes is reduced
as a result of such prepayment.

      

      (y)Optional and Contingent
Prepayments.  As provided in Sections 8.2 of the
Agreement.

      

      E.Purchaser
Representations.  Each Series B Purchaser represents and
warrants that the representations and warranties set forth in Section 6 of the
Agreement are true and correct on the date hereof with the same force and effect
as if each reference to “Series A Notes” set forth therein was modified to
refer the “Series B Notes”,  each reference to “Initial Purchaser” set
forth therein was modified to refer the “Series B Purchaser” and each reference
to “this Agreement” therein was modified to refer to the Agreement as
supplemented by this Supplemental Note Purchase Agreement.

      

      F.Series B Notes Issued under and
Pursuant to Agreement.  Except as specifically provided above,
the Series B Notes shall be deemed to be issued under, to be subject to and to
have the benefit of all of the terms and provisions of the Agreement as the same
may from time to time be amended and supplemented in the manner provided
therein.

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

      The
execution hereof by the Series B Purchasers shall constitute a contract among
the Company and the Series B Purchasers for the uses and purposes hereinabove
set forth.  By their acceptance hereof, each of the Series B
Purchasers shall also be deemed to have accepted and agreed to the terms and
provisions of the Agreement, as in effect on the date hereof.

       

      
        	 
      	
                CH
      Energy Group, Inc.

              
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                By
      

              	
                /s/
      Christopher M. Capone

              
	 
      	 
      	
                Christopher
      M. Capone

              
	 
      	 
      	
                Executive
      Vice President and

              
	 
      	 
      	
                Chief
      Financial Officer

              

      

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

       

      This
Agreement is hereby accepted and agreed to as of the date thereof.

      

      
        	 
      	
                      
                  Thrivent
      Financial for Lutherans

                

              
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                By:

              	/s/
      Alan D. Onstad
	 
      	 
      	
                Name:
      Alan D. Onstad

              
	 
      	 
      	
                Title:
      Senior Director, Private Investments

              
	 
      	 
      	 
      
	 
      	
                      
                  Modern
      Woodmen Of America

                

              
	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                By:

              	
                /s/
      Michael E. Dau

              
	 
      	 
      	
                Name:
      Michael E. Dau

              
	 
      	 
      	
                Title:
      Manager, Fixed Income Division

              

      

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

      Annex
1

      

      Series
B Notes Aggregate Principal and Interest Payments

      

      
        	 	 	
                Payment
      Date

              	 	
                Beginning
      Balance

              	 	 	
                Interest

              	 	 	
                Principal

              	 	 	
                Total
      Payment

              	 	 	
                Ending
      Principal

              	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	0	 	
                15-Dec-09

              	 	 	23500000.00	 	 	 	249126.11	 	 	 	0.00	 	 	 	 	 	 	23500000.00	 
	 	1	 	
                15-Jun-10

              	 	 	23500000.00	 	 	 	799000.00	 	 	 	0.00	 	 	 	799000.00	 	 	 	23500000.00	 
	 	2	 	
                15-Dec-10

              	 	 	23500000.00	 	 	 	799000.00	 	 	 	0.00	 	 	 	799000.00	 	 	 	23500000.00	 
	 	3	 	
                15-Jun-11

              	 	 	23500000.00	 	 	 	799000.00	 	 	 	462768.04	 	 	 	1261768.04	 	 	 	23037231.96	 
	 	4	 	
                15-Dec-11

              	 	 	23037231.96	 	 	 	783265.89	 	 	 	478502.16	 	 	 	1261768.04	 	 	 	22558729.80	 
	 	5	 	
                15-Jun-12

              	 	 	22558729.80	 	 	 	766996.81	 	 	 	494771.23	 	 	 	1261768.04	 	 	 	22063958.57	 
	 	6	 	
                15-Dec-12

              	 	 	22063958.57	 	 	 	750174.59	 	 	 	511593.45	 	 	 	1261768.04	 	 	 	21552365.12	 
	 	7	 	
                15-Jun-13

              	 	 	21552365.12	 	 	 	732780.41	 	 	 	528987.63	 	 	 	1261768.04	 	 	 	21023377.49	 
	 	8	 	
                15-Dec-13

              	 	 	21023377.49	 	 	 	714794.83	 	 	 	546973.21	 	 	 	1261768.04	 	 	 	20476404.28	 
	 	9	 	
                15-Jun-14

              	 	 	20476404.28	 	 	 	696197.75	 	 	 	565570.30	 	 	 	1261768.04	 	 	 	19910833.98	 
	 	10	 	
                15-Dec-14

              	 	 	19910833.98	 	 	 	676968.36	 	 	 	584799.69	 	 	 	1261768.04	 	 	 	19326034.29	 
	 	11	 	
                15-Jun-15

              	 	 	19326034.29	 	 	 	657085.17	 	 	 	604682.88	 	 	 	1261768.04	 	 	 	18721351.41	 
	 	12	 	
                15-Dec-15

              	 	 	18721351.41	 	 	 	636525.95	 	 	 	625242.10	 	 	 	1261768.04	 	 	 	18096109.32	 
	 	13	 	
                15-Jun-16

              	 	 	18096109.32	 	 	 	615267.72	 	 	 	646500.33	 	 	 	1261768.04	 	 	 	17449608.99	 
	 	14	 	
                15-Dec-16

              	 	 	17449608.99	 	 	 	593286.71	 	 	 	668481.34	 	 	 	1261768.04	 	 	 	16781127.65	 
	 	15	 	
                15-Jun-17

              	 	 	16781127.65	 	 	 	570558.34	 	 	 	691209.70	 	 	 	1261768.04	 	 	 	16089917.95	 
	 	16	 	
                15-Dec-17

              	 	 	16089917.95	 	 	 	547057.21	 	 	 	714710.83	 	 	 	1261768.04	 	 	 	15375207.11	 
	 	17	 	
                15-Jun-18

              	 	 	15375207.11	 	 	 	522757.04	 	 	 	739011.00	 	 	 	1261768.04	 	 	 	14636196.11	 
	 	18	 	
                15-Dec-18

              	 	 	14636196.11	 	 	 	497630.67	 	 	 	764137.38	 	 	 	1261768.04	 	 	 	13872058.74	 
	 	19	 	
                15-Jun-19

              	 	 	13872058.74	 	 	 	471650.00	 	 	 	790118.05	 	 	 	1261768.04	 	 	 	13081940.69	 
	 	20	 	
                15-Dec-19

              	 	 	13081940.69	 	 	 	444785.98	 	 	 	816982.06	 	 	 	1261768.04	 	 	 	12264958.63	 
	 	21	 	
                15-Jun-20

              	 	 	12264958.63	 	 	 	417008.59	 	 	 	844759.45	 	 	 	1261768.04	 	 	 	11420199.18	 
	 	22	 	
                15-Dec-20

              	 	 	11420199.18	 	 	 	388286.77	 	 	 	873481.27	 	 	 	1261768.04	 	 	 	10546717.91	 
	 	23	 	
                15-Jun-21

              	 	 	10546717.91	 	 	 	358588.41	 	 	 	903179.63	 	 	 	1261768.04	 	 	 	9643538.27	 
	 	24	 	
                15-Dec-21

              	 	 	9643538.27	 	 	 	327880.30	 	 	 	933887.74	 	 	 	1261768.04	 	 	 	8709650.53	 
	 	25	 	
                15-Jun-22

              	 	 	8709650.53	 	 	 	296128.12	 	 	 	965639.93	 	 	 	1261768.04	 	 	 	7744010.61	 
	 	26	 	
                15-Dec-22

              	 	 	7744010.61	 	 	 	263296.36	 	 	 	998471.68	 	 	 	1261768.04	 	 	 	6745538.92	 
	 	27	 	
                15-Jun-23

              	 	 	6745538.92	 	 	 	229348.32	 	 	 	1032419.72	 	 	 	1261768.04	 	 	 	5713119.20	 
	 	28	 	
                15-Dec-23

              	 	 	5713119.20	 	 	 	194246.05	 	 	 	1067521.99	 	 	 	1261768.04	 	 	 	4645597.21	 
	 	29	 	
                15-Jun-24

              	 	 	4645597.21	 	 	 	157950.31	 	 	 	1103817.74	 	 	 	1261768.04	 	 	 	3541779.47	 
	 	30	 	
                15-Dec-24

              	 	 	3541779.47	 	 	 	120420.50	 	 	 	1141347.54	 	 	 	1261768.04	 	 	 	2400431.93	 
	 	31	 	
                15-Jun-25

              	 	 	2400431.93	 	 	 	81614.69	 	 	 	1180153.36	 	 	 	1261768.04	 	 	 	1220278.57	 
	 	32	 	
                15-Dec-25

              	 	 	1220278.57	 	 	 	41489.47	 	 	 	1220278.57	 	 	 	1261768.04	 	 	 	0.00	 
	 	 	 	 
      	 	 	 	 	 	 	 	 	 	 	23500000.00	 	 	 	39451041.31	 	 	 	 	 

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

      Exhibit
A

      Supplemental
Representations

      

      The
Company represents and warrants to each Series B Purchaser that except as
hereinafter set forth in this Exhibit A, each of the
representations and warranties set forth in Section 5 of the Agreement is
true and correct as of the date hereof with respect to the Series B Notes with
the same force and effect as if each reference to “Series A Notes” set
forth therein was modified to refer the “Series B Notes” and each reference to
“this Agreement” therein was modified to refer to the Agreement as supplemented
by this Supplemental Note Purchase Agreement.  The Section and
Schedule references hereinafter set forth correspond to the similar sections of
the Note Purchase Agreement which are supplemented hereby:

      

      

      
        
          	
                  1.

                	
                  Schedule 5.4 to
      the Note
      Purchase Agreement hereby is supplemented by the addition of the
      following:

                

        

      

      

      
        	
                 

                Subsidiary

              	 	
                 

                Jurisdiction of
      Organization

              	 	
                Ownership
      of 

                Shares/Equity
      Interests

              
	
                CH
      - Greentree, LLC

              	 	
                New
      York

              	 	
                100%
      by the Subsidiary Guarantor

              
	
                CH
      - Lyonsdale, LLC

              	 	
                New
      York

              	 	
                100%
      by the Subsidiary Guarantor

              
	
                CH
      Shirley Wind LLC

              	 	
                New
      York

              	 	
                100%
      by the Subsidiary Guarantor

              
	
                Shirley
      Wind Delaware LLC

              	 	
                Delaware

              	 	
                90%
      by CH Shirley Wind, LLC

              
	
                Shirley
      Wind, LLC

              	 	
                Wisconsin

              	 	
                100%
      by Shirley Wind Delaware LLC

              

      

      

      
        
          	
                  2.

                	
                  Schedule 5.4 to
      the Note
      Purchase Agreement hereby is supplemented by the addition of the
      following:

                

        

      

      

      Board of Directors of the
Company:

      Edward T.
Tokar

      

      Senior Officers of the
Company:

      John E.
Gould, Executive Vice President and General Counsel

      James P.
Laurito, Executive Vice President

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      
        
          	
                  3.

                	
                  Section
      5.15.  Any Material change in the outstanding Debt of the
      Company and its Subsidiaries since March 31, 2009 is reflected in the
      Company’s Quarterly Report on Form 10-Q for the quarter ended September
      30, 2009 (including the issuance on September 30, 2009, by Central Hudson
      Gas & Electric Corporation of $24,000,000 of its 5.80% Medium Term
      Notes, Series F, due November 1,
2039).

                

        

      

    

     

     

    2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]